Eyelid-Sparing Adjuvant Radiation Therapy for Renal Cell Carcinoma

2006 ◽  
Vol 220 (3) ◽  
pp. 198-200 ◽  
Author(s):  
Madhavi Kurli ◽  
Paul T. Finger ◽  
Susan Schneider ◽  
Lawrence B. Tena
Keyword(s):  
Renal Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy

Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis

2019 ◽  
Vol 2 (4) ◽  
pp. 448-455 ◽  
Author(s):  
Iván A. Rodríguez-Fernández ◽  
Laura Rodríguez-Romo ◽  
David Hernandez-Barajas ◽  
Galileo A. Gonzalez-Conchas ◽  
Adrian Verdines-Perez ◽  
...  
Keyword(s):  
Systematic Review ◽  
Renal Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Radical Nephrectomy ◽  
Meta Analysis ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy ◽  
Localized Renal Cell Carcinoma

scholarly journals Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma

2019 ◽  
Vol 2019 ◽  
pp. 1-4 ◽  
Author(s):  
An Uche ◽  
Chad Sila ◽  
Tad Tanoura ◽  
James Yeh ◽  
Neil Bhowmick ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Complete Response ◽  
Heavily Pretreated ◽  
Treatment Paradigm ◽  
Endothelial Growth Factor

Cabozantinib represents an established vascular endothelial growth factor- (VEGF-) tyrosine kinase inhibitor (TKI) in the treatment paradigm of metastatic renal cell carcinoma (mRCC). Its activity in mRCC patients with brain metastases (BMs) has been largely underreported in prospective clinical trials. We present the unique case of a heavily pretreated mRCC patient with BMs who achieved a brain complete response to cabozantinib prior to receiving radiation therapy. We end with a literature review and discussion of the biologic rationale and growing evidence supporting the intracranial activity of cabozantinib.

scholarly journals Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer

2019 ◽  
Vol 12 (2) ◽  
pp. 381-388 ◽  
Author(s):  
Kyung Hwa Choi ◽  
Jeong Yong Jeon ◽  
Young-Eun Lee ◽  
Seung Won Kim ◽  
Sang Yong Kim ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Renal Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Synergistic Activity
Sign in / Sign up

Export Citation Format

Share Document